Send to

Choose Destination
Leuk Res. 2013 Feb;37(2):190-6. doi: 10.1016/j.leukres.2012.10.015. Epub 2012 Nov 15.

Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia.

Author information

Division Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany.


In vivo effects of the DNA hypomethylating agent 5-aza-2'-deoxycytidine (DAC) upon the epigenome of acute myeloid leukemia (AML) patients are scarcely studied in primary blasts. Here, we sequentially assessed DNA methylation and transcriptome changes in myeloblasts of DAC-treated AML patients. DNA methylation changes were detected in all patients already after the first series of infusion (median: 6 days). LINE1 analysis indicated global DNA methylation decrease in 7/8 patients. Gene-specific hypomethylating effects were not directly linked to mRNA expression changes. In conclusion, complex DAC-induced DNA methylation changes occur very early and imply mechanisms distinct from non-hypomethylating cytosine analogs.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center